Clinical Trials Directory

Trials / Completed

CompletedNCT04989205

Community Based Cannabis Cessation Program

Examining a Community Based Intervention for Cannabis Smoking Cessation in Norway - an Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
Sorlandet Hospital HF · Other Government
Sex
All
Age
16 Years
Healthy volunteers

Summary

The study examined a community based cannabis cessation program in Norway (CCP). The CCP uses a combination of cognitive therapy and psychoeducation and covers the normal withdrawal period for cannabis smoking cessation (up to 8 weeks), comprising \~15 individual sessions. From 2005 onwards, the CCP was implemented as a low-threshold community-based program in several Norwegian municipalities, e.g., Kristiansand, Fredrikstad and Oslo. The study had an observational one-group pre- / post test design. Outcomes was changes in cannabis use, mental distress, well-being, social network and sense of coherence (SoC) measured post-intervention (T2) and at a 3 months follow-up (T3).

Conditions

Interventions

TypeNameDescription
BEHAVIORALCannabis cessation ProgramLundqvist and Ericsson developed the 'Cannabis Cessation Program' (CCP, Nordic abbreviation: HAP) in Sweden in the 1990s. The method uses a combination of cognitive therapy and psychoeducation and covers the normal withdrawal period for cannabis smoking cessation (up to 8 weeks), comprising \~15 individual sessions. It describes a medical, a psychological, and a social phase, in which the participant is helped to recognize and address typical problems related to each phase, e.g., physical and psychological withdrawal problems. The overarching aim of the program is to help cannabis users to reorganize thinking patterns that developed while they were using cannabis and increase their social and psychological coping skills in relation to quitting cannabis use. The CCP manual has been translated into eight languages, e.g., Norwegian.

Timeline

Start date
2013-06-02
Primary completion
2017-01-31
Completion
2017-01-31
First posted
2021-08-04
Last updated
2026-02-19

Locations

3 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT04989205. Inclusion in this directory is not an endorsement.